| 1 |
Gilligan M, McGuigan C, McKeon A. Paraneoplastic Neurologic Disorders. Curr Neurol Neurosci Rep 2023;23:67-82. [PMID: 36781586 DOI: 10.1007/s11910-023-01250-w] [Reference Citation Analysis]
|
| 2 |
Ramanathan S, Brilot F, Irani SR, Dale RC. Origins and immunopathogenesis of autoimmune central nervous system disorders. Nat Rev Neurol 2023;19:172-90. [PMID: 36788293 DOI: 10.1038/s41582-023-00776-4] [Reference Citation Analysis]
|
| 3 |
Cai L, Chen H, Shi Z, Wang X, Du Q, Zhang Y, Lang Y, Kong L, Luo W, Mou Z, Lin X, Zhou H. Non-immune system comorbidity in neuromyelitis optica spectrum disorders. J Clin Neurosci 2023;107:16-22. [PMID: 36462412 DOI: 10.1016/j.jocn.2022.11.008] [Reference Citation Analysis]
|
| 4 |
Apiraksattayakul N, Songwisit S, Owattanapanich W, Tisavipat N, Siritho S, Prayoonwiwat N, Rattanathamsakul N, Jitprapaikulsan J. AQP4-IgG-positive neuromyelitis optica spectrum disorder and temporally detected neoplasms: case report and systematic review. Mult Scler Relat Disord 2022;68:104212. [PMID: 36242805 DOI: 10.1016/j.msard.2022.104212] [Reference Citation Analysis]
|
| 5 |
Palmer DA, Dooley H, Pipis M, Patten P, Silber E. A Novel approach using O-CVP to treat paraneoplastic NMO spectrum disorder associated with follicular lymphoma. BMJ Case Rep 2022;15:e252822. [DOI: 10.1136/bcr-2022-252822] [Reference Citation Analysis]
|
| 6 |
Cacciaguerra L, Sechi E, Rocca MA, Filippi M, Pittock SJ, Flanagan EP. Neuroimaging features in inflammatory myelopathies: A review. Front Neurol 2022;13:993645. [DOI: 10.3389/fneur.2022.993645] [Reference Citation Analysis]
|
| 7 |
Hickman SJ. Paraneoplastic Syndromes in Neuro-Ophthalmology. Ann Indian Acad Neurol 2022;25:S101-5. [PMID: 36589030 DOI: 10.4103/aian.aian_102_22] [Reference Citation Analysis]
|
| 8 |
Neuromyelitis Optica Spectrum Disorders and Glial Fibrillary Acidic Protein Autoimmunity. Autoimmune Encephalitis and Related Disorders of the Nervous System 2022. [DOI: 10.1017/9781108696722.012] [Reference Citation Analysis]
|
| 9 |
Autoimmune and Inflammatory Encephalopathies as Complications of Cancer. Autoimmune Encephalitis and Related Disorders of the Nervous System 2022. [DOI: 10.1017/9781108696722.017] [Reference Citation Analysis]
|
| 10 |
General Approach to Diagnosis. Autoimmune Encephalitis and Related Disorders of the Nervous System 2022. [DOI: 10.1017/9781108696722.003] [Reference Citation Analysis]
|
| 11 |
Loda E, Arellano G, Perez-Giraldo G, Miller SD, Balabanov R. Can Immune Tolerance Be Re-established in Neuromyelitis Optica? Front Neurol 2021;12:783304. [PMID: 34987468 DOI: 10.3389/fneur.2021.783304] [Reference Citation Analysis]
|
| 12 |
Mahler JV, de Brito MH, Miyahara-felipe L, Ayres AS, Araújo HA, Silva GD. Paraneoplastic AQP-4 IgG negative neuromyelitis optica spectrum disorder (NMOSD) associated with large-cell high-grade undifferentiated carcinoma of unknown primary site: A case report and review of paraneoplastic NMOSD. Neuroimmunology Reports 2022;2:100110. [DOI: 10.1016/j.nerep.2022.100110] [Reference Citation Analysis]
|
| 13 |
Blackburn KM, Vernino S. Paraneoplastic syndromes. Handbook of Neuro-Oncology Neuroimaging 2022. [DOI: 10.1016/b978-0-12-822835-7.00011-1] [Reference Citation Analysis]
|
| 14 |
Gudkova VV, Kimelfeld EI, Paderina VP, Koshurnikov DS, Ulianov DI, Ermakov DS, Maliutina NA. Opticoneuromyelitis associated with melanoma. Case report. Consilium Medicum 2021;23:884-90. [DOI: 10.26442/20751753.2021.11.201159] [Reference Citation Analysis]
|
| 15 |
Böcskei Z, Viinikka E, Dormegny L, Bigaut K, Speeg C. [Paraneoplastic ophthalmopathies]. J Fr Ophtalmol 2021:S0181-5512(21)00442-3. [PMID: 34598825 DOI: 10.1016/j.jfo.2021.08.002] [Reference Citation Analysis]
|
| 16 |
Shahmohammadi S, Doosti R, Shahmohammadi A, Azimi A, Sahraian MA, Fattahi MR, Naser Moghadasi A. Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: A systematic review. Mult Scler Relat Disord 2021;56:103227. [PMID: 34536774 DOI: 10.1016/j.msard.2021.103227] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 17 |
Tardo L, Wang C, Rajaram V, Greenberg BM. Pediatric paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian teratoma. Mult Scler 2021;:13524585211037582. [PMID: 34423664 DOI: 10.1177/13524585211037582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Lopez JA, Denkova M, Ramanathan S, Dale RC, Brilot F. Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease. Clin Transl Immunology 2021;10:e1316. [PMID: 34336206 DOI: 10.1002/cti2.1316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 19 |
Derdelinckx J, Reynders T, Wens I, Cools N, Willekens B. Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD. Int J Mol Sci 2021;22:7925. [PMID: 34360690 DOI: 10.3390/ijms22157925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Ikeguchi R, Shimizu Y, Shimomura A, Suzuki M, Shimoji K, Motohashi T, Yamamoto T, Shibata N, Kitagawa K. Paraneoplastic AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma: A Case Report and Literature Review. Neurol Neuroimmunol Neuroinflamm 2021;8:e1045. [PMID: 34285095 DOI: 10.1212/NXI.0000000000001045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Blaes F. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes. Expert Rev Neurother 2021;21:675-86. [PMID: 33960258 DOI: 10.1080/14737175.2021.1927713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Morimoto T, Hayashida S, Yamasaki K, Sasahara Y, Takaki T, Yatera K. Paraneoplastic neuromyelitis optica spectrum disorder associated with malignant melanoma: A case report. Thorac Cancer 2021;12:1775-9. [PMID: 33951331 DOI: 10.1111/1759-7714.13965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Gibril M, Walters R. Neuromyelitis optica spectrum disorder as a paraneoplastic syndrome: a rare and challenging diagnosis. BMJ Case Rep 2021;14:e239389. [PMID: 33947671 DOI: 10.1136/bcr-2020-239389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 24 |
Lee JK, Kwon S, Han JH, Yoon SE, Kim BJ, Kang ES. Increased proportion of CD20+ T cells after rituximab treatment in patient with neuromyelitis optica later diagnosed with lung B-cell lymphoma: A case report. J Neuroimmunol 2021;355:577564. [PMID: 33862419 DOI: 10.1016/j.jneuroim.2021.577564] [Reference Citation Analysis]
|
| 25 |
Cohen DA, Gise R, Gaier ED. Serum Biomarkers in Neuro-Ophthalmology: When to Test. Semin Ophthalmol 2021;36:322-8. [PMID: 33689572 DOI: 10.1080/08820538.2021.1897856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 26 |
Jitprapaikulsan J, Paul P, Thakolwiboon S, Mittal SO, Pittock SJ, Dubey D. Paraneoplastic neurological syndrome: an evolving story. Neurooncol Pract 2021;8:362-74. [PMID: 34277016 DOI: 10.1093/nop/npab002] [Reference Citation Analysis]
|
| 27 |
Pruitt AA. Neoplastic Myelopathies. Continuum (Minneap Minn) 2021;27:121-42. [PMID: 33522739 DOI: 10.1212/CON.0000000000000964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 28 |
Dinoto A, Bosco A, Sartori A, Bratina A, Bellavita G, Pasquin F, Cheli M, Manganotti P. Hiccups, severe vomiting and longitudinally extensive transverse myelitis in a patient with prostatic adenocarcinoma and Aquaporin-4 antibodies. J Neuroimmunol 2021;352:577488. [PMID: 33498007 DOI: 10.1016/j.jneuroim.2021.577488] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Wildemann B, Jarius S, Franz J, Ruprecht K, Reindl M, Stadelmann C. MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis. Acta Neuropathol 2021;141:127-31. [PMID: 33078290 DOI: 10.1007/s00401-020-02236-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 30 |
Zhang YH, Cheng YH, Cai G, Zhang YJ. Expression and significance of aquaporin-4 in thyroid carcinoma. Mult Scler Relat Disord 2021;48:102726. [PMID: 33418309 DOI: 10.1016/j.msard.2020.102726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 31 |
Bien CG, Schänzer A, Dargvainiene J, Dogan-onugoren M, Woermann F, Strickler A. Co-occurrence of antibodies against dipeptidyl-peptidase-like protein-6 and aquaporin-4 during a case of paraneoplastic encephalitis. Clinical Neurology and Neurosurgery 2020;197:106093. [DOI: 10.1016/j.clineuro.2020.106093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Papeix C, Beigneux Y, Maillart E, de Seze J, Lubetzki C, Vukusic S, Collongues N, Marignier R. A comparative evaluation of different neuromyelitis optica spectrum disorder sets of criteria. Eur J Neurol 2020;27:2250-6. [PMID: 32559008 DOI: 10.1111/ene.14414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 33 |
Conrad K, Shoenfeld Y, Fritzler MJ. Precision health: A pragmatic approach to understanding and addressing key factors in autoimmune diseases. Autoimmun Rev 2020;19:102508. [PMID: 32173518 DOI: 10.1016/j.autrev.2020.102508] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 34 |
Han S, Sharma RA, Sekhon H, Munoz D, Albreiki DH. Aquaporin-4 immunoglobulin-G-positive neuromyelitis optica spectrum disorder associated with small cell lung carcinoma. Can J Ophthalmol 2020;55:e129-32. [PMID: 32115187 DOI: 10.1016/j.jcjo.2020.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 35 |
Blackburn K, Wang C, Greenberg B. Two cases of aquaporin-4 positive neuromyelitis optica associated with T-cell lymphoma. Journal of Neuroimmunology 2020;338:577092. [DOI: 10.1016/j.jneuroim.2019.577092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 36 |
Rotstein DL, Sawicka K, Bharatha A, Montalban X, Lipton JH. CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two cases. Mult Scler 2020;26:1121-4. [DOI: 10.1177/1352458519892914] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 37 |
Yi S, Park H. A rare case of aquaporin-4-antibody-positive neuromyelitis optica associated with bladder cancer. Mult Scler Relat Disord 2020;38:101499. [PMID: 31812041 DOI: 10.1016/j.msard.2019.101499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 38 |
Sepulveda M, Delgado-García G, Blanco Y, Sola-Valls N, Martinez-Lapiscina EH, Armangué T, Montejo C, Pulido-Valdeolivas I, Martinez-Hernandez E, Ariño H, Escudero D, Ruiz-García R, Llufriu S, Dalmau J, Graus F, Saiz A. Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus. Neurol Neuroimmunol Neuroinflamm 2019;6:e607. [PMID: 31471461 DOI: 10.1212/NXI.0000000000000607] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 39 |
Fang W, Zheng Y, Cai M, Zhang Y. Neuromyelitis optica spectrum disorder with lung adenocarcinoma and intraductal papillary mucinous neoplasm. Multiple Sclerosis and Related Disorders 2019;32:77-80. [DOI: 10.1016/j.msard.2019.04.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 40 |
Abel A, McClelland C, Lee MS. Critical review: Typical and atypical optic neuritis. Surv Ophthalmol 2019;64:770-9. [PMID: 31229520 DOI: 10.1016/j.survophthal.2019.06.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 41 |
Yuan J, Jia Z, Qin W, Hu W. Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer. Clin Interv Aging 2019;14:1039-44. [PMID: 31239653 DOI: 10.2147/CIA.S202102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 42 |
Liao W, Li C, Tang Y, Huang F, Kuang H, Liang S, Yang Y. Aquaporin-4 antibody positive short transverse myelitis associated with breast cancer. Multiple Sclerosis and Related Disorders 2019;30:119-22. [DOI: 10.1016/j.msard.2019.02.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 43 |
Bernard-Valnet R, Cobo-Calvo A, Siegfried A, Marasescu R, Bonnan M, Ballan G, Ellie E, Bauer J, Uro-Coste E, Marignier R, Brassat D. Paraneoplastic neuromyelitis optica and ovarian teratoma: A case series. Mult Scler Relat Disord 2019;31:97-100. [PMID: 30954932 DOI: 10.1016/j.msard.2019.03.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 44 |
Graus F, Dalmau J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors. Nat Rev Clin Oncol 2019;16:535-48. [DOI: 10.1038/s41571-019-0194-4] [Cited by in Crossref: 123] [Cited by in F6Publishing: 129] [Article Influence: 30.8] [Reference Citation Analysis]
|
| 45 |
Okada K, Kobata M, Naruke S. Neuromyelitis optica spectrum disorder with area postrema syndrome. Neurol Clin Pract 2019;9:173-5. [PMID: 31041136 DOI: 10.1212/CPJ.0000000000000586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 46 |
Sonar SA, Lal G. Overview of Mechanisms Underlying Neuroimmune Diseases. Contemporary Clinical Neuroscience 2019. [DOI: 10.1007/978-3-030-19515-1_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 47 |
Muñiz-castrillo S, Honnorat J. Paraneoplastic Neurological Syndromes. Contemporary Clinical Neuroscience 2019. [DOI: 10.1007/978-3-030-19515-1_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 48 |
Lambert J, Mejia S, Vojdani A. Plant and human aquaporins: pathogenesis from gut to brain. Immunol Res 2019;67:12-20. [DOI: 10.1007/s12026-018-9046-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 49 |
Deuel LM, Bunch ME. A case of paraneoplastic neuromyelitis optica associated with small cell lung carcinoma. Journal of Neuroimmunology 2018;316:130-2. [DOI: 10.1016/j.jneuroim.2018.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 50 |
Beauchemin P, Iorio R, Traboulsee AL, Field T, Tinker AV, Carruthers RL. Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation. Multiple Sclerosis and Related Disorders 2018;20:37-42. [DOI: 10.1016/j.msard.2017.12.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
|
